این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Nanomedicine Journal، جلد ۹، شماره ۳، صفحات ۲۰۵-۲۱۵
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Synthesis, physicochemical characterization and pharmaceutical function of niosomal nanoparticles-encapsulated bioactive compound for osteosarcoma treatment
چکیده انگلیسی مقاله Objective(s): The purpose of this study is to synthesizing and characterizing niosomes containing curcumin in order to delivery to bone cancer cells. Nano-carriers were synthesized using thin film method and curcumin was loaded into them by active hydration method.Materials and Methods: The optimal formula was selected based on the encapsulation efficiency and release profile. Then the physicochemical properties of nanoparticles such as size and zeta potential, morphology and system-drug interaction were evaluated by using DLS, SEM, AFM and FTIR methods. Finally, the toxicity of nanosystems on bone cancer cell line MG-63 as resistant cells to treatment was examined by MTT assay. Results: Niosomes containing curcumin with size of 90.8 nm, PDI of 0.236, zeta potential of -8.9 and encapsulation rate of 73.5 ± 1.8 have slow-release profile. The maximum release rate of the drug for this nano-carrier in healthy and cancerous within 72 hr was 60.12% and 64.35% respectively. IR and morphological investigations showed no chemical interaction between curcumin and nanocarrier and the particles are spherical in shape. The results of the MTT assay also showed that by encapsulating curcumin, its effect on bone cancer cells increased and the resistance of MG-63 cells to treatment decreased. Conclusion: The results of this study showed that niosomes containing curcumin with appropriate physicochemical properties can improve the treatment process in bone cancer cells and also reduce the resistance of this cell to the drug and could be proposed as a new therapeutic strategy to help the treatment of osteosarcoma.
کلیدواژه‌های انگلیسی مقاله Bioactive compound, Curcumin, MG-63 cells, Niosomal nanoparticles, Osteosarcoma
نویسندگان مقاله | Mohammad Taebpour
Depatment of Medical Biotechnology, Faculty of Medicine, Shahid Sadoughi University of Medical sciences, Yazd, Iran


| Milad Akhlaghi
Department of Clinical Biochemistry, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran


| Shayesteh Shahriyari
Department of Medical Biotechnology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran


| Saeedeh Hajihosseini
Department of Mechanical Engineering, University of Tehran, Tehran, Iran


| Bibi Fatemeh Haghiralsadat
Depatment of Medical Biotechnology, Faculty of Medicine, Shahid Sadoughi University of Medical sciences, Yazd, Iran|Department of Advanced Medical Sciences and Technologies, School of Paramedicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran


| Fatemeh Oroojalian
Department of Advanced Technologies, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran|Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran


| Davood Tofighi
Department of Psychology, University of New Mexico, Albuquerque, New Mexico, USA
نشانی اینترنتی https://nmj.mums.ac.ir/article_20151.html
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده مقاله پژوهشی
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات